Steere Pharmaceutical Consulti Cary, NC - 27513

Steere Pharmaceutical Consulti is categorized under Business Consultants in Cary, NC and active since 2008.

Steere Pharmaceutical Consulti was established in 2008, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Business Consultants business, which does work in the B2B market, and is classified as a Business Consultants, under code number 3254120 by the NAICS.

If you are seeking more information, feel free to contact Elizabeth Steere, Principal at the company’s single location by writing to 100 Pennsbury Court, Cary, North Carolina NC 27513 or by phoning (919) 460-6251. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Steere Pharmaceutical Consulti
Contact Person: Elizabeth Steere, Principal
Address: 100 Pennsbury Court, Cary, North Carolina 27513
Phone Number: (919) 460-6251
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 2008
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Business Consultants
SIC Code: 8748
NAICS Code: 3254120
Share This Business:

Steere Pharmaceutical Consulti was started in 2008 to provide professional Business Consultants under the SIC code 8748 and NAICS code 3254120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Elizabeth Steere, Principal for inquiries that concern Steere Pharmaceutical Consulti by calling the company number (919) 460-6251, as your correspondence is most welcome. Additionally, the physical location of the single location of Steere Pharmaceutical Consulti can be found at the coordinates 35.771107,-78.838444 as well as the street address 100 Pennsbury Court in Cary, North Carolina 27513.

For its online presence, you may visit Steere Pharmaceutical Consulti’s website at and engage with its social media outlets through on Twitter and on Facebook.